Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous.
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;11(1):20-30. Unique Identifier : AIDSLINE MED/96130043 Wilson JE; Wright LL; Martin JL; Haire SE; Ray PH; Painter GR; Furman PA; Division of Biochemistry, Burroughs Wellcome Co., Research; Triangle Park, North Carolina, USA.
Abstract:
Recombinant wild type (wt) and T215Y HIV-1 reverse transcriptase (RT) were isolated using three methods designated A, B, and C. The three samples of wt RT were kinetically indistinguishable with respect to dTTP turnover on poly(rA).p(dT)10. However, whereas the kinetic constants for dTTP and AZTTP for both T215Y B and T215Y C were similar to those of wt protein, T215Y A exhibited a twofold increase in Km value for dTTP and a 13-fold increase in Ki value for AZTTP with respect to wt protein purified in the same manner. We further investigated this observation by studying the denaturation of wt RT by urea. The urea denaturation curves monitored by fluorescence and circular dichroism spectroscopy were not coincident with the denaturation curve monitored by enzyme activity and yielded Cm values (the concentration of urea at which 50% of the protein is denatured) of 4.1 and 2.0 M urea, respectively. The noncoincidence of the transition curves reflects two separable, sequential, noncooperative conformational changes in the molecule: (a) from a catalytically active to an inactive conformation, and (b) from a catalytically inactive to a denatured, unfolded conformation. We therefore used denaturation as detected by changes in enzyme activity to compare the conformational stability of the three samples of wt and T215Y RT A, B, and C. The Cm values for T215Y RT did not differ from those of the respective wt; however, differences in Cm values were noted depending on how the protein was isolated. This suggested that the heterogeneity of the recombinant RT was due to small differences in conformation at or near the active site.
Keywords: Antiviral Agents/PHARMACOLOGY Chromatography, Affinity Chromatography, Gel Electrophoresis, Polyacrylamide Gel Enzyme Stability Escherichia coli/ENZYMOLOGY/GENETICS Human HIV-1/*ENZYMOLOGY/GENETICS Kinetics Protein Conformation Protein Denaturation/DRUG EFFECTS Recombinant Fusion Proteins/CHEMISTRY/GENETICS/ISOLATION & PURIF RNA-Directed DNA Polymerase/CHEMISTRY/*GENETICS/ISOLATION & PURIF Spectrometry, Fluorescence Thymine Nucleotides/PHARMACOLOGY Urea/PHARMACOLOGY Zidovudine/ANALOGS & DERIVATIVES/PHARMACOLOGY JOURNAL ARTICLE 960430
M9640800
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
